Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Items 101–200 of 999
Targeting Innate Immunity in Cancer Therapy
Rameshbabu, S., Labadie, B. W., Argulian, A., & Patnaik, A. (2021) · Vaccines · doi:10.3390/vaccines9020138 · Cited by 129
“For example, one study in pancreatic adenocarcinoma identified five subsets of TAMs each with distinct gene expression profiles which correlate with the diverse immunosuppressive or immune-stimulatory functions listed above [40,41].”
BackgroundHan, X., Chen, H., Huang, D., Chen, H., Fei, L., Cheng, C., Huang, H., Yuan, G.-C., & Guo, G. (2018) · Genome Biology · doi:10.1186/s13059-018-1426-0 · Cited by 116
“To date, single-cell technology has been used to study cellular heterogeneity in a wide range of systems [24], including the hierarchy of tumor cells [32, 33], tissue and organs [34–37], developing embryos [38, 39] and in vitro differentiation systems [40–42].”
MethodIntegration of single-cell RNA-seq data into population models to characterize cancer metabolism
Damiani, C., Maspero, D., Di Filippo, M., Colombo, R., Pescini, D., Graudenzi, A., Westerhoff, H. V., Alberghina, L., Vanoni, M., & Mauri, G. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006733 · Cited by 113
Zhu, L., Narloch, J. L., Onkar, S., Joy, M., Broadwater, G., Luedke, C., Hall, A. H. S., Kim, R., Pogue–Geile, K. L., Sammons, S. L., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0755-1 · Cited by 125
“For further validation, we applied four methods; namely GSVA using the immune signatures from Davoli and Tomborero, and two methods of deconvolution (CIBERSORT and TIMER) to a publicly available single cell RNA-seq dataset [17], in which immune cell percentages were available using cell markers.”
MethodCirculating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
Tellez-Gabriel, M., Heymann, M.-F., & Heymann, D. (2019) · Theranostics · doi:10.7150/thno.34337 · Cited by 111
Transcriptomics and solid tumors: The next frontier in precision cancer medicine
Tsimberidou, A. M., Fountzilas, E., Bleris, L. G., & Kurzrock, R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.007 · Cited by 130
Sun, T., Song, D., Li, W. V., & Li, J. J. (2021) · Genome Biology · doi:10.1186/s13059-021-02367-2 · Cited by 109
“Already, scRNA-seq technologies have led to breakthroughs in understanding biological processes such as stem cell differentiation and embryogenesis [9, 10], neurological disorders [11, 12], and tumorigenesis [13, 14].”
BackgroundYu, T., Ma, D., Liu, Y., Xiao, Y., Gong, Y., Jiang, Y., Shao, Z.-M., Hu, X., & Di, G. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.003 · Cited by 127
Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy
Zhang, E., Ding, C., Li, S., Zhou, X., Aikemu, B., Fan, X., Sun, J., Zheng, M., & Yang, X. (2023) · Biomarker Research · doi:10.1186/s40364-023-00460-1 · Cited by 126
“B-cell and T-cell aggregation in the TME has traditionally been considered a favourable prognostic feature, which has also been validated using single-cell techniques [48].”
Droplet-based single cell RNAseq tools: a practical guide
Salomon, R., Kaczorowski, D., Valdes-Mora, F., Nordon, R. E., Neild, A., Farbehi, N., Bartonicek, N., & Gallego-Ortega, D. (2019) · Lab on a Chip · doi:10.1039/c8lc01239c · Cited by 109
Coulton, A., Murai, J., Qian, D., Thakkar, K., Lewis, C. E., & Litchfield, K. (2024) · Nature Communications · doi:10.1038/s41467-024-49885-8 · Cited by 135
Levitin, H. M., Yuan, J., Cheng, Y. L., Ruiz, F. J., Bush, E. C., Bruce, J. N., Canoll, P., Iavarone, A., Lasorella, A., Blei, D. M., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188557 · Cited by 106
Inertial-ordering-assisted droplet microfluidics for high-throughput single-cell RNA-sequencing
Moon, H., Je, K., Min, J.-W., Park, D., Han, K., Shin, S., Park, W., Yoo, C. E., & Kim, S. (2018) · Lab on a Chip · doi:10.1039/c7lc01284e · Cited by 109
Self-citationImmune cell profiling in cancer: molecular approaches to cell-specific identification
Lyons, Y. A., Wu, S. Y., Overwijk, W. W., Baggerly, K., & Sood, A. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0031-0 · Cited by 153
“20 Single-cell analysis of tumor-infiltrating T cells can illustrate varying phenotypes of T cells, including naive, regulatory, cytotoxic, exhaustion, and costimulatory subtypes, which can lead to predicting the type of immune therapy that the tumor is most likely to respond to.(18) NanoString’s nCounter analysis sys…”
BackgroundLeptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments
Lin, T., & Hsiao, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062870 · Cited by 122
Youssef, K. K., Narwade, N. P., Arcas, A., Márquez-Galera, Á., Jiménez-Castaño, R., López-Blau, C., Fazilaty, H., García-Gutierrez, D., Cano, A., Galcerán, J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00839-5 · Cited by 133
Single-Cell RNA Sequencing with Spatial Transcriptomics of Cancer Tissues
Ahmed, R., Zaman, T., Chowdhury, F., Mraiche, F., Tariq, M., Ahmad, I. S., & Hasan, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063042 · Cited by 117
Buzdin, A. A., Sorokin, M., Garazha, A., Sekacheva, M. I., Kim, E. L., Zhukov, N. V., Wang, Y., Li, X., Kar, S., Hartmann, C. J., et al. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.06.003 · Cited by 112
scGAC: a graph attentional architecture for clustering single-cell RNA-seq data
Yi, C. X., & Ma, X. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac099 · Cited by 114
scAlign: a tool for alignment, integration, and rare cell identification from scRNA-seq data
Johansen, N., & Quon, G. (2019) · Genome Biology · doi:10.1186/s13059-019-1766-4 · Cited by 100
Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer
Eum, H. H., Kwon, M., Ryu, D., Jo, A., Chung, W., Kim, N., Hong, Y., Son, D., Kim, S. T., Lee, J., et al. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00538-y · Cited by 110
Self-citationSingle-cell RNA sequencing in cancer: Applications, advances, and emerging challenges
Sun, G., Li, Z., Rong, D., Zhang, H., Shi, X., Yang, W., Zheng, W., Sun, G., Wu, F., Cao, H., et al. (2021) · Molecular Therapy - Oncolytics · doi:10.1016/j.omto.2021.04.001 · Cited by 99
“A TME-exclusive intercellular communicating process was suggested from the receptor-ligand analyzing process.109 Chung et al.110 performed scRNA-seq to BC and studied 515 cells from 11 patients.”
BackgroundMethodInfluentialRhee, J., Jung, Y. C., Kim, K. R., Yoo, J., Kim, J., Lee, Y., Ko, Y. H., Lee, H. H., Cho, B. C., & Kim, T. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0201 · Cited by 112
“As demonstrated in a study (34), single-cell, sequencing-based immune profiling may alleviate the purity-associated biases.”
BackgroundSelf-citationTagliazucchi, G. M., Wiecek, A. J., Withnell, E., & Secrier, M. (2023) · Nature Communications · doi:10.1038/s41467-023-36439-7 · Cited by 103
“established between tumour cells found in an EPI, hEMT, or MES state and other cells in the tumour microenvironment in the Chung et al.(57) dataset.”
BackgroundMethodInfluentialZou, G., Wang, J., Xu, X., Xu, P., Zhu, L., Yu, Q., Peng, Y., Guo, X., Li, T., & Zhang, X. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00613-5 · Cited by 110
Kabir, M. F., Chen, T., & Ludwig, S. A. (2022) · Healthcare Analytics · doi:10.1016/j.health.2022.100125 · Cited by 124
Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications
Su, M., Pan, T., Chen, Q.-Z., Zhou, W., Gong, Y., Xu, G., Yan, H.-Y., Li, S., Shi, Q.-Z., Zhang, Y., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00434-8 · Cited by 143
“Similarly, strong epithelial-to-mesenchymal transition (EMT) and stemness signatures were observed in metastatic breast cancer cells [15, 16].”
BackgroundA temporal perspective for tumor-associated macrophage identities and functions
Blériot, C., Dunsmore, G., Alonso‐Curbelo, D., & Ginhoux, F. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.002 · Cited by 111
Lin, T. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188715 · Cited by 115
Multiomics technologies: role in disease biomarker discoveries and therapeutics
Dar, M. A., Arafah, A. M., Bhat, K. A., Khan, A., Khan, M. S., Ali, A., Ahmad, S. M., Rashid, S. M., & Rehman, M. U. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac017 · Cited by 113
Li, C., & Hua, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897366 · Cited by 95
FOXA1 overexpression suppresses interferon signaling and immune response in cancer
He, Y., Wang, L., Wei, T., Xiao, Y., Sheng, H., Su, H., Hollern, D. P., Zhang, X., Ma, J., Wen, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147025 · Cited by 106
“While a significant fraction of FOXA1 mutations in cancer are C-terminal truncation mutations (29, 30), we demonstrated that different from the SBR-deficient mutant FOXA1 (1-247), the two PCa-associated C-terminal truncation mutants FOXA1 (1-290) and FOXA1 (1-268) (29, 30) remained the ability to bind to STAT2 and sup…”
BackgroundHigh Throughput Single Cell RNA Sequencing, Bioinformatics Analysis and Applications
Huang, X., Liu, S., Wu, L. L., Jiang, M., & Hou, Y. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-0502-3_4 · Cited by 96
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
Jacquemin, V., Antoine, M., Dom, G., Detours, V., Maenhaut, C., & Dumont, J. E. (2022) · Cancers · doi:10.3390/cancers14020280 · Cited by 103
“As demonstrated by single-cell RNA sequencing (scRNAseq) for solid and circulating tumor cells, heterogeneity at the single-cell level may also result from transcription [8,48,49].”
BackgroundAbe, S., Nagata, H., Crosby, E. J., Inoue, Y., Kaneko, K., Liu, C.-X., Yang, X., Wang, T., Acharya, C. R., Agarwal, P., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003717 · Cited by 96
“7 Consequently, modifying the polarization of TAM in the TME has become a focus of attempts to increase the efficacy of BC immunotherapy.”
Clinical multi-omics strategies for the effective cancer management
Yoo, B. C., Kim, K., Woo, S. M., & Myung, J. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.08.010 · Cited by 86
Self-citationWang, Q., Guldner, I. H., Golomb, S. M., Sun, L., Harris, J. A., Lü, X., & Zhang, S. (2019) · Nature Communications · doi:10.1038/s41467-019-11729-1 · Cited by 106
Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity
Zhang, R., Tu, J., & Liu, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.008 · Cited by 91
What are the applications of single-cell RNA sequencing in cancer research: a systematic review
Li, L., Xiong, F., Wang, Y., Zhang, S., Gong, Z., Li, X., He, Y., Shi, L., Wang, F., Liao, Q., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01955-1 · Cited by 112
“[110] conducted transcriptomic analysis of 515 single cells from patients with different breast cancer subtypes, revealing the gene expression patterns of cancer cells and immune cells.”
MethodSystems Immunology: Learning the Rules of the Immune System
Villani, A., Sarkizova, S., & Hacohen, N. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053035 · Cited by 102
“…melanoma (145), glioblastoma (146), low-grade glioma (147), isocitrate dehydrogenase–mutant glioma (148), colorectal tumors (149), breast cancer (150), liver cancer (151), renal cell carcinoma (152), ovarian cancer (153), chronic lymphocytic leukemia (154), acute lymphoblastic leukemia (155),…”
BackgroundOshi, M., Gandhi, S., Yan, L., Tokumaru, Y., Wu, R., Yamada, A., Matsuyama, R., Endo, I., & Takabe, K. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06633-0 · Cited by 95
“The GSE75688 cohort has single-cell RNA-sequencing data of cancer cells, myeloid cells, immune cells, and stromal cells in breast cancer [34], which was obtained from Gene Expression Omnibus.”
BackgroundSpotClean adjusts for spot swapping in spatial transcriptomics data
Ni, Z., Prasad, A., Chen, S., Halberg, R. B., Arkin, L. M., Drolet, B. A., Newton, M. A., & Kendziorski, C. M. (2022) · Nature Communications · doi:10.1038/s41467-022-30587-y · Cited by 102
Yamashita, N., Long, M. D., Fushimi, A., Yamamoto, M., Hata, T., Hagiwara, M., Bhattacharya, A., Hu, Q., Wong, K., Liu, S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002115 · Cited by 95
Advanced tools and methods for single-cell surgery
Shakoor, A., Gao, W.-D., Zhao, L.-B., Jiang, Z.-D., & Sun, D. (2022) · Microsystems & Nanoengineering · doi:10.1038/s41378-022-00376-0 · Cited by 72
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
Alchahin, A. M., Mei, S., Τσέα, Ι., Hirz, T., Kfoury, Y. S., Dahl, D. M., Wu, C., Subtelny, A. O., Wu, S., Scadden, D. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33375-w · Cited by 93
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Gong, L., Yan, Q., Zhang, Y., Fang, X., Liu, B., & Guan, X. (2019) · 癌症:英文版 · doi:10.1186/s40880-019-0393-5 · Cited by 90
Hu, L., Su, L., Cheng, H., Mo, C., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2123 · Cited by 88
Onkar, S., Cui, J., Zou, J., Cardello, C., Cillo, A. R., Uddin, M. R., Sagan, A., Joy, M., Osmanbeyoglu, H. U., Pogue–Geile, K. L., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00527-w · Cited by 96
Single-cell sequencing and its applications in head and neck cancer
Qi, Z., Barrett, T. F., Parikh, A. S., Tirosh, I., & Puram, S. V. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104441 · Cited by 88
Ke, M. S., Elshenawy, B., Sheldon, H., Arora, A., & Buffa, F. M. (2022) · BioEssays · doi:10.1002/bies.202200084 · Cited by 89
Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing
Zhang, L., & Zhang, Z. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0658 · Cited by 79
Chen, P., Wang, Y., Li, J., Bo, X., Wang, J., Nan, L., Wang, C., Ba, Q., Liu, H., & Wang, H. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.462 · Cited by 100
A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer
Djomehri, S. I., Burman, B., González, M. E., Takayama, S., & Kleer, C. G. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-0498-7 · Cited by 90
“Because of growing interest in patient tumor derived organoids for purposes of biobanking (Wetering et al. 2015) and single cell sequencing (Chung et al. 2017), these efforts have mainly focused on the primary epithelial compartment, but there is a great need to expand our understanding of patient…”
BackgroundPoirion, O., Zhu, X., Ching, T., & Garmire, L. X. (2018) · Nature Communications · doi:10.1038/s41467-018-07170-5 · Cited by 78
An Integrated Epigenomic and Transcriptomic Map of Mouse and Human αβ T Cell Development
Chopp, L. B., Gopalan, V., Ciucci, T., Ruchinskas, A. J., Rae, Z., Lagarde, M., Gao, Y., Li, C., Bosticardo, M., Pala, F., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.024 · Cited by 91
“We sorted CD69lo/+ thymocytes, from either H2-Ab1−/− or B2m−/− mice, separately captured them using the 10x Genomics Chromium platform and processed them for scRNAseq (Chung et al., 2017) (Fig.”
MethodExploring the cellular landscape of circular RNAs using full-length single-cell RNA sequencing
Wu, W., Zhang, J., Cao, X., Cai, Z., & Zhao, F. (2022) · Nature Communications · doi:10.1038/s41467-022-30963-8 · Cited by 82
CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
Azangou‐Khyavy, M., Ghasemi, M., Khanali, J., Boroomand-Saboor, M., Jamalkhah, M., Soleimani, M., & Kiani, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02062 · Cited by 85
Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
Finotello, F., & Eduati, F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00430 · Cited by 81
Chen, C., Guo, Q., Fu, H., Yu, J., Wang, L., Sun, Y., Zhang, J., & Duan, Y. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120988 · Cited by 80
Li, X., Zhou, L., Luo, H., Zhu, Q. R., Zuo, L., Liu, G.-Y., Feng, C., Zhao, J., Zhang, Y., & Li, X. (2019) · Aging · doi:10.18632/aging.102149 · Cited by 78
“Correlations between the genes of interest (MIR210HG and MUC1-C) and functional states in 3 different single-cell datasets (CancerSEA), EXP0052 [17], EXP0053 [18] and EXP0054 [19] were plotted.”
BackgroundIntrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1
Lung, D. K., Reese, R., & Alarid, E. T. (2020) · Hormones and Cancer · doi:10.1007/s12672-020-00388-0 · Cited by 83
Strategies to target long non-coding RNAs in cancer treatment: progress and challenges
Dizaji, B. F. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00074-4 · Cited by 83
Deep learning tackles single-cell analysis—a survey of deep learning for scRNA-seq analysis
Flores, M. A., Liu, Z., Zhang, T., Hasib, M. M., Chiu, Y., Ye, Z., Paniagua, K., Jo, S., Zhang, J., Gao, S., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab531 · Cited by 79
From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer
Gutschner, T., Richtig, G., Haemmerle, M., & Pichler, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9718-5 · Cited by 78
Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment
Song, Q., Ruiz, J., Xing, F., Lo, H., Craddock, L., Pullikuth, A., Miller, L. D., Soike, M. H., O’Neill, S. S., Watabe, K., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05124-2 · Cited by 81
Zhang, S., Liu, Z., Wu, D., Chen, L., & Xie, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.596318 · Cited by 78
Tyler, M. P. H., & Tirosh, I. (2021) · Nature Communications · doi:10.1038/s41467-021-22800-1 · Cited by 80
NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer
Guo, H., Golczer, G., Wittner, B. S., Langenbucher, A., Zachariah, M. A., Dubash, T. D., Hong, X., Comaills, V., Burr, R., Ebright, R. Y., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.016 · Cited by 85
A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer
Savage, P., Blanchet-Cohen, A., Revil, T., Badescu, D., Saleh, S. M. I., Wang, Y.-C., Zuo, D., Liu, L., Bertos, N. R., Munoz-Ramos, V., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.015 · Cited by 72
scCancer: a package for automated processing of single-cell RNA-seq data in cancer
Guo, W., Wang, D., Wang, S., Shan, Y., Liu, C., & Gu, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa127 · Cited by 75
Control of Dendritic Cell Function Within the Tumour Microenvironment
Hari‐Gupta, Y., Khanom, A., & Acton, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.733800 · Cited by 77
Biological and Medical Importance of Cellular Heterogeneity Deciphered by Single-Cell RNA Sequencing
Gupta, R. K., & Kuźnicki, J. (2020) · Cells · doi:10.3390/cells9081751 · Cited by 80
“Another study performed scRNA-seq of estrogen receptor α-positive breast cancer cells following 17β-estradiol stimulation and reconstructed the dynamic estrogen-responsive transcriptional network from discrete-time points into a pseudotemporal continuum [64].”
BackgroundBeausang, J. F., Wheeler, A. J., Chan, N. H., Hanft, V. R., Dirbas, F. M., Jeffrey, S. S., & Quake, S. R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713863114 · Cited by 74
“The disadvantage is that some important cellular details are missed, such as the heavy- and light-chain pairing and the expression of functional markers, such as CD4, CD8, FOXP3, CTLA4, and PDL1 (19, 34), unless cells have been previously sorted (15, 35).”
BackgroundSingle-Cell RNA Sequencing: Technological Progress and Biomedical Application in Cancer Research
Xu, C., Zheng, Y., & Xu, K. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00777-0 · Cited by 84
“For instance, the majority of tumor epithelial cells exhibit luminal and luminal progenitor markers, though a minority express myoepithelial cell markers such as ACTA2 and TAGLN [19].”
BackgroundYeo, S. K., Zhu, X., Okamoto, T., Hao, M., Wang, C., Lu, P., Lu, L. J., & Guan, J. (2020) · eLife · doi:10.7554/elife.58810 · Cited by 70
Rodríguez‐Bautista, R., Ortega-Gómez, A., Hidalgo‐Miranda, A., Zentella‐Dehesa, A., Villarreal-Garza, C. M., Ávila‐Moreno, F., & Arrieta, O. G. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0514-z · Cited by 71
“and other researcher groups have been working on the identification and validation of the differential expression of lncRNAs by RNA massive sequencing methods (RNA-seq) [9, 79], as well as, more recently single-cell RNA sequencing (scRNASeq) that allows the quantification of transcript expression profiles for individu…”
BackgroundYan, B. Y., Garcet, S., Gulati, N., Kiecker, F., Fuentes‐Duculan, J., Gilleaudeau, P., Sullivan-Whalen, M. M., Shemer, A., Mitsui, H., & Krueger, J. G. (2018) · Experimental Dermatology · doi:10.1111/exd.13805 · Cited by 72
Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology
Valdes-Mora, F., Handler, K., Law, A. M. K., Salomon, R., Oakes, S. R., Ormandy, C. J., & Gallego-Ortega, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02582 · Cited by 68
“Thus, in the last 5 years, studies on single-cell transcriptome of tumors of different cancer types have emerged, this includes (Table 2): glioma (150, 151, 157), melanoma (112), colorectal cancer (159), hepatocellular carcinoma (113, 152), renal carcinoma (153), nonsmall-cell lung cancer (NSCLC) (115, 116, 154), brea…”
BackgroundBao, X., Shi, R., Zhao, T., & Wang, Y. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12670 · Cited by 75
“Previous studies have investigated the relationship between immune cell populations and the clinical outcomes of cancer patients (Bao et al., 2019b; Bindea et al., 2013; Chung et al., 2017; Homma et al., 2014).”
BackgroundCancer biology deciphered by single-cell transcriptomic sequencing
Li, Y., Jin, J., & Bai, F. (2021) · Protein & Cell · doi:10.1007/s13238-021-00868-1 · Cited by 87
“…et al. characterized the expression signatures and programs that promote metastatic progression in several rare subsets of primary triple-negative breast cancer using scRNA-seq, and identified strong EMT and stemness signatures, which may drive tumor progression and metastasis (Chung et al., 2017).”
BackgroundA systems approach to clinical oncology uses deep phenotyping to deliver personalized care
Yurkovich, J. T., Tian, Q., Price, N. D., & Hood, L. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0273-6 · Cited by 79
Lavy, M., Gauttier, V., Poirier, N., Barillé‐Nion, S., & Blanquart, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.702785 · Cited by 79
Qiu, J., Qu, X., Wang, Y., Guo, C., Lv, B., Jiang, Q., Su, W., Wang, L., & Hua, K. (2023) · Advanced Science · doi:10.1002/advs.202204951 · Cited by 81
Ding, S., Qiao, N., Zhu, Q., Tong, Y., Wang, S., Chen, X., Tian, Q., Xiao, Y., & Shen, K. (2023) · 癌症:英文版 · doi:10.1002/cac2.12429 · Cited by 74
“Several scRNA-seq studies have been carried out in breast cancer, either focusing on single cell populations in TNBC, such as tissueresident memory T cells [15] and B cells [16], describing the general characteristics of immune cells [17], or depicting the comprehensive tumor environment by sequencing total cells isol…”
BackgroundMuliaditan, T., Opzoomer, J. W., Caron, J., Okesola, M., Kosti, P., Lall, S. K., Hemelrijck, M. V., Dazzi, F., Tutt, A. N. J., Grigoriadis, A. E., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2587 · Cited by 67
“The single-cell RNA-seq (34) dataset was extracted from the NCBI GEO, accession code GSE75688.”
BackgroundMethodInfluentialSun, H., Zhang, L., Wang, Z., Gu, D., Zhu, M., Cai, Y., Li, L., Tang, J., Huang, B., Bosco, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41318-2 · Cited by 82
Yan, C. W., Yang, J., Saleh, N., Chen, S., Ayers, G. D., Abramson, V. G., Mayer, I. A., & Richmond, A. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105207 · Cited by 77
Jang, B., Han, W., & Kim, I. A. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.11.003 · Cited by 69
Self-citationTang, W., Sun, G., Ji, G., Feng, T., Zhang, Q., Cao, H., Wu, W., Zhang, X., Liu, C., Liu, H.-Y., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007030 · Cited by 71
Precision Oncology Decision Support: Current Approaches and Strategies for the Future
Kurnit, K. C., Dumbrava, E. E. I., Litzenburger, B. C., Khotskaya, Y. B., Johnson, A. M., Yap, T. A., Rodon, J. A., Zeng, J., Shufean, M. A., Bailey, A. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2494 · Cited by 74
“With the exciting advances made possible by single-cell techniques in the assessment of tumor heterogeneity and subclonal detection of alterations (30, 31), it is likely that liquid biopsies will complement rather than replace tumor testing in the foreseeable future.”
BackgroundMechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes
McQuerry, J. A., Chang, J. T., Bowtell, D. D. L., Cohen, A. L., & Bild, A. H. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1587-4 · Cited by 70
“pinpoint subtype-specific differences in gene expression [55].”
mPGES-1 and ALOX5/-15 in tumor-associated macrophages
Weigert, A., Strack, E., Snodgrass, R. G., & Brüne, B. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9731-3 · Cited by 70
Cancer classification of single-cell gene expression data by neural network
Kim, B., Yu, K., & Lee, P. C.-W. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz772 · Cited by 65
The current landscape of single-cell transcriptomics for cancer immunotherapy
Guruprasad, P., Lee, Y. G., Kim, K. H., & Ruella, M. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201574 · Cited by 66
Self-citationDeng, H., Gao, Y., Trappetti, V., Hertig, D., Karatkevich, D., Losmanová, T., Urzì, C., Ge, H., Geest, G. A., Bruggmann, R., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04453-5 · Cited by 69
“Indeed, single-cell RNA-sequencing of cancer cells revealed significant differences in LDHB expression between and within cancer, stroma, and immune subpopulations of primary breast cancer tumors [59] (see also https:// www.”
BackgroundDeep learning in spatially resolved transcriptomics: a comprehensive technical view
Zahedi, R., Ghamsari, M. R. E., Argha, A., MacPhillamy, C., Beheshti, A., Alizadehsani, R., Lovell, N. H., Lotfollahi, M., & Alinejad‐Rokny, H. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae082 · Cited by 94
Paolillo, C., Londin, E. R., & Fortina, P. M. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2017.283895 · Cited by 70
Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis
Zhuang, X., Zhang, H., & Hu, G. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.04.005 · Cited by 68
Kanaya, N., Chang, G., Wu, X., Saeki, K., Bernal, L., Shim, H.-J., Wang, J., Warden, C., Yamamoto, T., Li, J., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0618-9 · Cited by 64
Noureen, N., Ye, Z., Chen, Y., Wang, X., & Zheng, S. (2022) · eLife · doi:10.7554/elife.71994 · Cited by 66
“…Materials and Methods 215 Single cell data sets and Signature scoring 216 We used single cell data sets from 10 published studies (Bi et al., 2021; Chung et al., 2017; 217 Darmanis et al., 2017; He et al., 2021; Lee et al., 2020; Ma et al., 2019; Neftel et al., 2019; 218 Puram et al., 2017;…”
Method
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.